AAV9 delivered bispecific nanobody attenuates amyloid burden in the gelsolin amyloidosis mouse model

Human Molecular Genetics, 2017, 26, 1353–1364. doi: 10.1093/hmg/ddx056

The Authors would like to apologize for a spelling error in the name of one of the co-authors. The correct spelling is Thierry VandenDriessche, in one word. This has now been corrected online.